InvestorsHub Logo
Followers 209
Posts 32167
Boards Moderated 1
Alias Born 06/30/2009

Re: changes_iv post# 114571

Sunday, 08/23/2015 12:11:46 PM

Sunday, August 23, 2015 12:11:46 PM

Post# of 146240
" Are you aware of any GLP toxicology studies that contradict KARD Scientific, Inc. non-GLP findings? "
I'm not well versed on the science. Have there been any GLP toxicology studies, whether contradictory or supportive of the non-GLP findings?

"Care to revise and extend your remarks based on Dr. Milton Boniuk's most recent STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES"
Since the time of that post I found that Dr. Boniuk's share purchases line up very nicely with the cash interest payments that he's received on his debentures.
It's truly magical:
1. Lends money to the company.
2. Receives cash interest payments from company.
3. Receives additional interest in the form of shares.
4. Uses the cash interest payments to buy shares in the open market.
It's all perfectly proper and above board. Questions only arise when one fills in the blanks with actual numbers.

“I have had a wonderful time but this wasn't it.”
..........Groucho

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News